JETO HomeIssue Contents

P-170 peptides with low similarity to the human proteome:
Tracing an effective and safe biological way towards effective and safe cancer chemotherapy

Darja Kanduc, Giuseppe Novello and Roberto Mazzanti

We propose low-similarity P-170 peptide-based antibodies to neutralize the multidrug resistance phenomenon and, consequently, improve the treatment regimens for cancer chemotherapy. As a first step in the experimental validation of this approach, we report on the similarity analysis of the P-170 primary amino acid structure versus the human proteome and describe peptide motifs uniquely owned by the human P-170 glycoprotein.

Keywords: P-170, MDR, cancer chemotherapy, drug resistance, vaccines, low-similarity peptides

Full Text (IP)